AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

EVMN · NYSE · Biotechnology

Evommune

Develops chronic-inflammation therapies centered on EVO756 and EVO301 clinical programs.

$13.23

After-hours close+0.01 (+0.08%)

At close$13.22(−1.93%)

Date	Estimate	Reported	Surprise
Oct 2026	−$0.82	—	—
Aug 2026	−$0.66	−$0.89	−33.9%
May 2026	−$0.83	−$0.64	+22.9%
Mar 2026	−$0.82	−$1.43	−74.4%
Dec 2025	−$6.08	−$8.07	−32.7%

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise
Oct 16, 2026	−$0.82	—	—	$500.0K	—	—
Aug 6, 2026	−$0.66	−$0.89	−33.9%	$1.3M	$0	−100.0%
May 7, 2026	−$0.83	−$0.64	+22.9%	$722.2K	—	—
Mar 5, 2026	−$0.82	−$1.43	−74.4%	—	—	—
Dec 11, 2025	−$6.08	−$8.07	−32.7%	$3.3M	$10.0M	+200.0%